2007•Journal of the American Academy of DermatologyRequires access

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year

Phoebe A. Rich, Christopher E.M. Griffiths, Kristian Reich, Frank Oliver Nestle, Richard K. Scher, Shu Li, Stephen Xu, Ming-Chun Hsu, Cynthia A. Guzzo

Open publisher page 166 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 166 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Psoriasis, Infliximab, Onycholysis, Nail (fastener), Placebo, Dermatology, Nail disease

Back to paper search Browse research topics Original source

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year — Research Paper | ScholarLens